# The Effect of Ischaemic-Reperfusion and Remote Ischaemic Preconditioning in Man - A Bradykinin Dependent Pathway

> **NCT00965393** · NA · COMPLETED · sponsor: **University of Edinburgh** · enrollment: 12 (estimated)

## Conditions studied

- Ischaemic Heart Diseases

## Interventions

- **PROCEDURE:** Forearm vascular study
- **DRUG:** Placebo
- **DRUG:** bradykinin receptor antagonist (HOE-140)

## Key facts

- **NCT ID:** NCT00965393
- **Lead sponsor:** University of Edinburgh
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2010-10-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00965393

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00965393, "The Effect of Ischaemic-Reperfusion and Remote Ischaemic Preconditioning in Man - A Bradykinin Dependent Pathway". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00965393. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
